London, UK (PRWEB UK) 2 October 2013
PerkinElmer has expanded its range of prenatal screening test offerings to offer an early-onset preeclampsia screening test in the US, Zenopa.com reported September 16th. The article, “PerkinElmer launches preeclampsia screening test in US,” explained that the PreeclampsiaScreen T1 serum screening test is designed to precisely detect asymptomatic patients in the first trimester of pregnancy who are at high risk for developing the condition. Jim Corbett, senior vice-president and president for diagnostics and life sciences and technology for PerkinElmer, commented, “This first-of-its-kind screen is our latest commitment to providing clinicians with new, innovative ways to address some of today's most challenging prenatal clinical scenarios.” (http://www.zenopa.com/news/801637911/perkinelmer-launches-preeclampsia-screening-test-in-us)
Following this announcement, Yourwellness Magazine felt compelled to explore the complications associated with preeclampsia. According to Yourwellness Magazine, “If pre-eclampsia is not diagnosed and monitored, a number of serious complications can develop. Although complications from pre-eclampsia are rare, having severe pre-eclampsia or continuing to smoke with pre-eclampsia increases the risk of complications.” Yourwellnes Magazine explained that during an eclamptic convulsion, the mother’s arms, legs, neck or jaw will twitch involuntarily in repetitive, jerky movements. She may lose consciousness and may wet herself. The convulsions usually last less than a minute. (http://www.yourwellness.com/2013/06/complications-of-pre-eclampsia/#sthash.rFwehXYF.dpuf)
Yourwellness Magazine warned that while most women make a full recovery after having eclampsia, there is a small risk of permanent disability or brain damage if the convulsions are severe. Of those who have eclampsia, around one in 50 will die from the condition. Yourwellness Magazine added that unborn babies can suffocate during a seizure, and one in 14 may die. Yourwellness Magazine noted that magnesium sulphate can halve the risk of eclampsia and reduce the risk of the mother dying. It is now widely used to treat eclampsia after it has occurred, and to treat women who may be at risk of developing eclampsia.
To find out more, visit the gateway to living well at http://www.yourwellness.com.